Navigation Links
Public Policy Staffing Study Offers Benchmark Opportunity for Bio-Pharma and Medical Device Companies
Date:1/13/2012

CHAPEL HILL, N.C., Jan. 13, 2012 /PRNewswire/ -- Bio-Pharmaceutical and medical device leaders are re-evaluating their staffing and investment levels in light of increasing regulatory and market pressures in the U.S., according to analysts at research and consulting firm Best Practices, LLC.

To identify which resourcing strategies will best reduce risk and enhance growth in the quickly changing healthcare industry, Best Practices, LLC, a world-leader in biopharmaceutical benchmarking and best practice research, has launched a new study: "Public Affairs and Public Policy Staffing in the U.S. Marketplace for Biopharmaceutical and Medical Device Companies."

This landmark study comprises wide-ranging staffing investment insights from bio-pharma and medical device executives across areas such as Structure and Reporting Relationships, Staffing and Investment and Consolidated Staffing and Investment Efficiency Ratios for the following functions:

  • Government Affairs (State and Federal Government Relations and Public Policy)
  • Corporate Communications – External
  • Corporate Communication – Internal
  • Product Communications
  • Corporate Social Responsibility
  • Alliance Management

This critical research study represents the latest contribution of Best Practices, LLC to the life science industry's staffing and investment knowledge.  While previous studies have captured key metrics to identify optimal resource levels for maximum competitiveness, regulatory and other changes have continued to erode the effectiveness of the industry's proven business model -  a fact pressing executives to reconsider efficient levels of human and capital investment.

This latest study therefore offers an open benchmark opportunity for public affairs/public policy executives throughout the bio-pharma and medical device sectors.

For assistance or questions related to this study, contact research team leader Cameron Tew at ctew@best-in-class.com or (919) 767-9246. Responses are requested by Feb. 21, 2012.

There is no cost to participate, and all benchmark participants will receive the complete, blinded research results and analysis for free. This study will generate comparative metrics and executive insights that participants can use in the future to help assess what staffing and investment levels are right for different sizes of company.

All responses are blinded and aggregated to protect confidentiality. To view or participate in the online survey, follow this link: http://app.sgizmo.com/preview_survey.php?id=91334&k=I1283c7fxPu28NtobvbYNIfk4eEhy0&u=pwalve%40best-in-class%2ecom

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BNA Books Announces the Publication of the 2011 Cumulative Supplement to "Pharmaceutical Law: Regulation of Research, Development, and Marketing"
2. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
3. Successful Diabetes Product Launches Balance Digital & Traditional Public Relations Tools
4. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
5. BNA Books Announces the Publication of the 2011 Supplement to "Pharmaceutical Patent Law, Second Edition"
6. Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock
7. Ampio Responds to Recent Publications by Anonymous Short Sellers
8. Orexigen® Therapeutics Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
9. Utilizing Public Relation Strategies During Pharmaceutical Lifecycle Management for Greatest Impact on Brand and Consumer Base
10. Quest Diagnostics Launches Simplexa™ Dengue Test in Brazil, First Commercial Molecular Test Approved for Nations Public and Private Health Testing
11. Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... , ... March 23, 2017 ... ... financial services firm serving the families and businesses of the Norwalk and ... program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse ...
Breaking Medicine News(10 mins):